U.S. Stock News

NYSE:CNX
NYSE:CNXOil and Gas

Is CNX Resources (CNX) Fairly Valued After Recent Weakness In Its Share Price?

CNX Resources (CNX) shares eased slightly to close at US$35.39. Investors are now weighing recent returns that include a decline over the past week but a strong gain across the past 3 months. For CNX Resources, the near term tells a softer story than the longer horizon, with the share price down over the past week but still showing a 90 day share price return of 7.76% and a 1 year total shareholder return of 15.62%. This hints that recent weakness comes after a solid run, backed by multi year...
NYSE:SHAK
NYSE:SHAKHospitality

Shake Shack (SHAK) Could Be 27% Below Fair Value On Growth Narrative

Shake Shack (SHAK) has come under scrutiny after a steep share price decline over the past six months. This now sits alongside thin operating margins and limited free cash flow to reinvest in the business. Recent trading has been rough. The share price has dropped 30.19% year to date and the 1-year total shareholder return is down 41.15%, which suggests sentiment toward Shake Shack has cooled as investors reassess its growth prospects and risk profile. Seize the chance to compare Shake Shack...
NYSE:AX
NYSE:AXBanks

Axos Financial (AX) Pullback Puts Its Digital Banking Valuation Narrative To The Test

Axos Financial (AX) has been drawing attention after a recent pullback, with the share price closing at US$92.68 as returns weakened over the past month despite stronger performance over the past 3 months. Recent trading has cooled, with the 30 day share price return down 9.28% and the 7 day move also negative, even though Axos Financial still shows a 6.07% year to date share price gain and a very large 3 year total shareholder return of 135.77%. Scan the recent pullback in Axos Financial in...
NYSE:EQT
NYSE:EQTOil and Gas

EQT (EQT) Stock Could Be Undervalued On Current Earnings

EQT has delivered a powerful long term share price run, yet recent choppier returns are prompting investors to ask whether the current valuation still lines up with the company’s earnings power. With the stock now trading at US$53.12 after some short term softness, the key issue is how much of EQT’s profit story is already embedded in that price. Over the past 5 years EQT has returned 210.2%, which puts a lot of weight on the question of whether its earnings can continue to support that kind...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

What Could Fortinet (FTNT) Gain From Its New York Hub For Financial Clients?

Fortinet (NasdaqGS: FTNT) has opened a company-owned Innovation Hub in New York City focused on enterprise and financial clients. The flagship site is designed for technology demos, AI-focused cybersecurity research, hands-on training, and broader customer engagement programs. The New York facility targets financial sector partners and aims to address cybersecurity skill gaps through on-site education and workshops. Fortinet’s new New York Innovation Hub is a meaningful development that...
NYSE:OKE
NYSE:OKEOil and Gas

Why Did ONEOK (OKE) Move After Its Latest Update?

ONEOK (OKE) has moved into the spotlight after a fully subscribed cash tender offer of up to US$2 billion of long-term notes, paired with new post-reorganization charter and bylaw updates. ONEOK’s reorganization and the fully subscribed US$2b tender for long-dated notes come as the share price sits at US$94.72, with a 90-day share price return of 10.68% and a year-to-date share price gain of 27.41%. The 1-year total shareholder return of 37.59% indicates that momentum has been building rather...
NYSE:SLB
NYSE:SLBEnergy Services

SLB (SLB) Stock Still Looks Reasonable Following Its 125% Five Year Run

SLB has delivered a strong multi year share price run, which naturally raises a question for anyone looking at the stock today. Are the cash flows behind the business enough to support where the market now prices SLB? Over the past 5 years, SLB has returned 124.8%, which puts real weight on whether the current valuation is fully backed by its cash generation. Recent contract wins such as the Musuma-1 drilling and shifting activity between the Middle East and the Americas can reshape when and...
NYSE:EIX
NYSE:EIXElectric Utilities

Edison International (EIX) Stock May Be Cheap Based On Earnings

Edison International has seen a sharp pullback in recent weeks, which puts fresh focus on whether the current share price lines up with what its earnings can support. For investors, the question now is how the utility's profit stream stacks up against what the market is asking you to pay for it. The stock has fallen 23.6% over the past month, which puts recent price weakness front and centre in any discussion of what its earnings are worth today. The business relies on regulated utility...
NYSE:PNC
NYSE:PNCBanks

PNC Financial Services Group (PNC) Draws Valuation Attention As Conference Goals Lift The Narrative

Conference messaging puts PNC Financial Services Group in focus PNC Financial Services Group (PNC) has stepped into the spotlight after management used recent industry conferences to stress tighter cost control, positive operating leverage, and an ambition for record net interest income in 2025. Those talking points, paired with an emphasis on organic expansion, customer acquisition, and deeper franchise relationships, have led investors to reassess how the current share price aligns with the...
NasdaqGS:TYRA
NasdaqGS:TYRABiotechs

Tyra Biosciences (TYRA) Stock May Stay Pricey Following Mixed Trial Data

Tyra Biosciences has seen a sharp reset in sentiment after mixed bladder cancer trial data, and the stock is still sitting on a very strong 1 year gain. That combination puts a simple but important question on the table for investors who follow Tyra Biosciences, whether the current price can be squared with what its balance sheet and book value actually support. Over the past 12 months, Tyra Biosciences has returned about 105.7%, which raises the issue of how much of that move is backed by...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

Lyft (LYFT) Stock Still Sits Below Fair Value Despite 71% Fall

Lyft shares closed at US$15.69 after a mixed stretch, with the stock down 20.7% year to date, and the key issue now is whether that price still lines up with what the business earns. Over the past 5 years the share price has fallen 71.2%, which puts the focus firmly on whether the current valuation is still anchored to Lyft's earnings power. New union representation for California drivers and the expansion of robotaxi services with Waymo can influence future pay structures, cost per ride and...
NYSE:HXL
NYSE:HXLAerospace & Defense

Hexcel (HXL) Stock May Be 35% Undervalued On Carbon Fiber Demand News

Hexcel has delivered a 65.9% share price gain over the past 5 years, yet the real story for investors now is whether the current US$91.36 price is properly anchored to the cash the business can generate. With the stock giving back some ground over the past month, the question is shifting from momentum to what its cash flows actually justify. The 65.9% return over 5 years puts meaningful expectations into the Hexcel share price, which makes the link between that move and the company’s future...
NasdaqGS:SKHY
NasdaqGS:SKHYSemiconductor

SK hynix (NasdaqGS:SKHY) Becomes A Core Holding In A New U.S. ETF

SK hynix (NasdaqGS: SKHY) is a key holding in the newly launched KICK Korea Semiconductor Index ETF for U.S. investors. The ETF is listed in the United States and targets exposure to Korea's broader semiconductor value chain, with SK hynix as a core component. Fund marketing materials position SK hynix alongside other Korean chip specialists to give investors concentrated access to the sector through one vehicle. The KICK Korea Semiconductor Index ETF built around SK hynix only tells part of...
NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Backs Nucleic Acid Research In Nervous System Diseases

Eli Lilly (NYSE: LLY) has entered a research and collaboration agreement with QurCan Therapeutics focused on nucleic acid therapies. The partnership targets central and peripheral nervous system diseases using QurCan's proprietary delivery platform for nucleic acid drugs. The agreement combines joint R&D work with a direct investment by Eli Lilly in QurCan Therapeutics. This Eli Lilly and QurCan Therapeutics nucleic acid collaboration is a fresh development that investors may weigh alongside...
NYSE:CI
NYSE:CIHealthcare

What Is Putting Cigna Group (CI) Back In Focus?

Cigna Group (CI) has drawn fresh attention after recent share price moves put its current valuation back in focus for health insurance and pharmacy benefits investors who are watching large, diversified healthcare platforms. The recent move in Cigna Group’s share price to US$288.90 comes after a mixed stretch, with a 7 day share price return of 4.7% but a small decline over the last session. This hints at investors rebalancing short term enthusiasm against a more measured view of long term...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Is Bio-Techne (TECH) Reasonable On Cash Flow Or Too Rich?

Bio-Techne has seen a mixed share-price story, with a sizeable setback over longer periods but a much stronger picture over the past year. This puts the focus squarely on what investors are really paying for its cash flows. With the stock around US$72.34, the key issue is how well that price lines up with the cash the business can generate over time. The share price has fallen 44.2% over 5 years, which raises the question of whether the market has reset expectations for Bio-Techne's future...
NYSE:GWW
NYSE:GWWTrade Distributors

3 US Industrial Distributor Stocks Built For Rising Costs

Supply chains are heating up again, rates are climbing and geopolitical shocks are feeding through to freight, energy and component costs. That mix is punishing for some businesses, yet it can reward distributors and niche suppliers with real pricing power. If you care about which industrial stocks might handle this pressure better than others, keep reading. This article walks through three US industrial distributors exposed to these inflation and rate catalysts. The three industrial...
NYSEAM:CMCL
NYSEAM:CMCLMetals and Mining

Caledonia Mining (CMCL) Heads Into Capital Markets Day With Its Valuation Story Under Review

Capital Markets Day puts Caledonia Mining in the spotlight Caledonia Mining (CMCL) is holding a Capital Markets Day in New York on 16 September 2026, giving investors fresh detail on Blanket Mine performance, the Bilboes gold project and the broader financial outlook. Recent trading has been choppy for Caledonia Mining, with the share price slipping 1.74% over the last session and 4.69% over the past week. The stock has still posted a 10.28% 1-month share price return and a 20.76% 3-month...
NYSE:KRG
NYSE:KRGRetail REITs

Fitch Upgrade Might Change The Case For Investing In Kite Realty Trust (KRG)

Fitch Ratings recently upgraded Kite Realty Group Trust’s long-term issuer ratings and operating partnership ratings to BBB+ from BBB, citing sustained operational outperformance and progress under its Project Elevate capital recycling program. The agency highlighted how tight open-air retail supply and strong tenant demand have improved Kite Realty Group Trust’s pricing power, helping the landlord quickly re-lease space previously vacated by bankrupt tenants. We will now look at how Kite...
NYSE:UPS
NYSE:UPSLogistics

Why Is United Parcel Service (UPS) Cutting Amazon Volumes To Protect Margins?

United Parcel Service (NYSE:UPS) has reduced its Amazon delivery volumes by more than 50% as part of a margin-focused shift. Management is prioritising steadier margins, gross profit and operating cash flows over headline package volume and revenue growth. The cutback in Amazon volumes marks a new phase in how UPS balances large platform partnerships against profitability goals. The Amazon volume cut and margin focus are only one part of the wider UPS story that investors may want to...
NYSE:LNN
NYSE:LNNMachinery

Is Lindsay (LNN) A Bargain Or Fully Priced Following Mixed Returns?

Lindsay (LNN) has drawn fresh attention after recent trading left the share price at US$118.81. Investors are weighing mixed return figures across the past month, past 3 months and year. Recent action around Lindsay points to fading momentum, with a 7 day share price return that fell 3.52% and a year to date share price return that declined 1.93%, while the 1 year total shareholder return dropped 14.38%, compared with a 3 year total shareholder return of 6.87%. Compare Lindsay's recent...
NYSE:LZB
NYSE:LZBConsumer Durables

Is La Z Boy (LZB) Below Fair Value On Cash Flow?

La-Z-Boy shares have taken a sharp step back, which puts a fresh spotlight on whether the current market price still lines up with the cash the business can generate over time. With the stock now trading at US$30.32, the question is how well that quote reflects the furniture maker's underlying cash flows rather than just recent sentiment. The share price has fallen 27.6% over the past month, which puts recent cash flow expectations under much closer scrutiny. The business model leans heavily...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Nasdaq (NDAQ) Could Be 14% Undervalued On Its Push Deeper Into Tokenized Markets

Nasdaq (NDAQ) has pushed deeper into tokenized markets, expanding its collaboration with Payward, parent of crypto exchange Kraken, to advance the Nasdaq Equity Token framework and a new market surveillance agreement. Recent trading has been choppy for Nasdaq, with the share price down 2.56% on the day and 8.03% over 30 days. However, a 7.13% 90 day share price return and 82.41% three year total shareholder return suggest longer term momentum has previously been stronger than the current year...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

Neogen (NEOG) Could Be 6% Undervalued On Sales Pressure And Debt Fears

Fresh concerns around Neogen (NEOG) are back in focus after commentary flagged declining sales, weaker returns on capital, and a stretched net-debt-to-EBITDA ratio that could increase the likelihood of a future equity raise. Despite worries about weaker returns and leverage, the Neogen share price has been strong in the short term. It has a 37.18% 90 day share price return and a 75% year to date share price return at a last close of US$12.25. The 1 year total shareholder return of 132.45%...